Published ahead of print on July 20, 2006, doi:10.1164/rccm.200601-048OC Am. J. Respir. Crit. Care Med., Volume 174, Number 7, October 2006, 743-752 A more recent version of this article appeared on October 1, 2006
Submitted on January 12, 2006 Whole Body Periodic Acceleration Modifies Experimental Asthma in SheepWilliam M Abraham1*,1 Division of Pulmonary Disease and Critical Care Medicine, University of Miami at Mount Sinai Medical Center, Miami Beach, Florida, USA, 2 Department of Neonatology, Mount Sinai Medical Center, Miami Beach, Florida, USA * To whom correspondence should be addressed. E-mail: abraham{at}msmc.com.
Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation, is anti-inflammatory and so might be protective in asthma. Objectives: We determined if a non-invasive, motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide, modulates experimental asthma in sheep. Methods: Allergic sheep were either untreated (control), treated with pGz alone or after receiving intravenously, the nitric oxide synthase inhibitor, Nw -Nitro-L-arginine methyl ester (L-NAME), before aerosol challenge with Ascaris suum and the effect on antigen-induced airway responses determined. Bronchoalveolar lavage cells obtained 6 hours after antigen challenge were analyzed for nuclear factor-kappa beta activity in the respective groups. Results: One-hour pGz treatment prior to antigen challenge, reduced the early airway response and blocked the late airway response, but did not prevent the antigen-induced airway hyperresponsiveness 24 hours after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. Nuclear factor-kappa beta activity was 1.9- and 1.8- fold higher in the control and L-NAME+pGz groups, respectively, compared to pGz treated animals. Extending the pGz treatment to twice daily for 3 days and then 1 hour before antigen challenge blocked the early and late airway responses, the 24-hour airway hyperresponsiveness and airway inflammatory cell response. Conclusion: Whole body pGz modulates allergen-induced airway responses in allergic sheep Key words: Nitric oxide, non-invasive periodic acceleration, asthma therapy, animal models
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||